The Global Polyglycolic Acid Market was valued at USD 117 Million in 2024 and is projected to reach USD 153 Million in 2025, surging to USD 864 Million by 2032, growing at an exceptional Compound Annual Growth Rate (CAGR) of 39.2% during the forecast period (2025-2032). This explosive growth is being driven by stringent environmental regulations, expanding applications in the oil and gas sector for hydraulic fracturing, and the accelerating adoption of biodegradable medical devices and sustainable packaging solutions.

As the global economy pivots towards sustainability and circular materials, the spotlight is on the key polymer producers and biomaterial developers who are driving technological innovation and commercial-scale production. In this blog, we profile the Top 10 Companies in the Polyglycolic Acid Industry—a mix of established chemical giants, specialized biomaterial firms, and emerging market leaders shaping the future of high-performance biodegradable polymers.

---

🔟 1. Kureha Corporation

Headquarters: Tokyo, Japan
Key Offering: High-Purity PGA Resins, Medical-Grade PGA, Industrial-Grade PGA

Kureha Corporation is the global pioneer and dominant leader in the Polyglycolic Acid market, holding an estimated 38% revenue share. The company leverages its proprietary polymerization technology to produce high-molecular-weight PGA with exceptional mechanical strength and gas barrier properties. Kureha’s products are critical for applications ranging from oil and gas well stimulation to advanced medical sutures and biodegradable packaging films.

Innovation Initiatives:

• Proprietary ring-opening polymerization technology for superior product quality

• Recent capacity expansion in Japan to meet soaring global demand

• Strategic R&D focused on high-barrier packaging and medical device applications

Download FREE Sample Report: Polyglycolic Acid Market – View in Detailed Research Report

---

9️⃣ 2. Corbion N.V.

Headquarters: Amsterdam, Netherlands
Key Offering: PGA and PLGA copolymers, Bio-based polymers

Corbion N.V. is a leading global biobased chemicals company with a strong focus on sustainable polymer solutions. The company’s expertise in lactide and glycolide chemistry positions it as a key player in the development of PGA and its copolymers, particularly for medical and pharmaceutical applications where controlled biodegradation is critical.

Innovation Initiatives:

• Advanced PLGA copolymer technology for drug delivery systems

• Partnerships with TotalEnergies for improved raw material security

• Focus on expanding application scope in tissue engineering

---

8️⃣ 3. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Resomer® biopolymers, Medical-grade PGA, Custom polymer solutions

Evonik Industries is a global specialty chemicals leader with a formidable presence in high-performance biomaterials. Through its Resomer® product line, Evonik offers medically approved PGA and copolymer formulations that meet stringent regulatory requirements for implantable devices and controlled-release pharmaceutical applications.

Innovation Initiatives:

• Development of resorbable polymer systems for advanced medical devices

• Customized polymer solutions for specific customer applications

• Expansion of biomaterials portfolio through strategic acquisitions

---

7️⃣ 4. BMG Incorporated

Headquarters: Tokyo, Japan
Key Offering: PGA polymers, Biomaterial compounds

BMG Incorporated is a Japanese specialty chemical company with significant expertise in biodegradable polymers. The company has developed specialized PGA formulations that balance performance characteristics with cost-effectiveness, making PGA more accessible for industrial applications while maintaining the material’s essential properties.

Innovation Initiatives:

• Cost-optimized PGA formulations for industrial applications

• Development of PGA blends with enhanced processing characteristics

• Focus on Asian market expansion and application development

---

6️⃣ 5. Teleflex Incorporated

Headquarters: Wayne, Pennsylvania, USA
Key Offering: PGA-based medical devices, Surgical sutures

Teleflex Incorporated is a leading global provider of medical technologies, with substantial expertise in developing and manufacturing PGA-based medical products. The company utilizes PGA’s unique biodegradation properties to create advanced surgical sutures and other medical devices that eliminate the need for secondary removal procedures.

Innovation Initiatives:

• Advanced PGA suture technology with controlled absorption rates

• Integration of PGA in minimally invasive surgical devices

• Clinical research on PGA applications in various surgical specialties

---

5️⃣ 6. Shanghai Pujing Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Industrial-grade PGA, Cost-competitive PGA formulations

Shanghai Pujing Chemical has emerged as one of China’s fastest-growing PGA producers, capturing approximately 12% of the Chinese market. The company focuses on cost-competitive industrial-grade PGA formulations that meet the demanding requirements of oilfield applications, particularly in shale gas extraction where temporary plugging agents are essential.

Innovation Initiatives:

• Strategic partnerships with major oilfield service companies

• Development of PGA formulations optimized for high-temperature downhole conditions

• Expansion of production capacity to serve growing domestic demand

Download FREE Sample Report: Polyglycolic Acid Market – View in Detailed Research Report

---

4️⃣ 7. Samyang Biopharm

Headquarters: Seoul, South Korea
Key Offering: Pharmaceutical-grade PGA, Drug delivery polymers

Samyang Biopharm is a leading Korean company specializing in advanced biomaterials for pharmaceutical and medical applications. The company has developed sophisticated PGA and PLGA formulations for controlled drug delivery systems, leveraging PGA’s predictable degradation profile to create innovative pharmaceutical products with optimized release characteristics.

Innovation Initiatives:

• Advanced drug delivery systems using PGA copolymers

• Development of customized polymer formulations for specific APIs

• Expansion of GMP manufacturing capabilities for pharmaceutical applications

---

3️⃣ 8. Meta Biomed Co., Ltd.

Headquarters: Cheongju, South Korea
Key Offering: PGA-based medical devices, Dental and orthopedic biomaterials

Meta Biomed is a specialized Korean medical device company with significant expertise in developing PGA-based solutions for dental, orthopedic, and surgical applications. The company’s focus on clinically relevant product development has resulted in a portfolio of PGA-based medical devices that address specific clinical needs across multiple medical specialties.

Innovation Initiatives:

• Development of PGA-based bone graft materials and dental membranes

• Clinical validation of PGA devices in orthopedic and dental applications

• Expansion of international regulatory approvals for PGA medical devices

---

2️⃣ 9. Shenzhen Polymtek Biomaterial Co., Ltd.

Headquarters: Shenzhen, China
Key Offering: PGA resins, Biodegradable polymer compounds

Shenzhen Polymtek Biomaterial is a Chinese company focused on developing and manufacturing biodegradable polymers, including specialized PGA formulations. The company serves both domestic and international markets with cost-effective PGA solutions that balance performance requirements with economic considerations, particularly for packaging and industrial applications.

Innovation Initiatives:

• Development of PGA formulations for sustainable packaging applications

• Customized polymer compounding services for specific customer needs

• Expansion of production capabilities to serve global markets

---

1️⃣ 10. Huizhou Foryou Medical Device Co., Ltd.

Headquarters: Huizhou, China
Key Offering: PGA sutures, Absorbable medical devices

Huizhou Foryou Medical Device is a specialized Chinese manufacturer of absorbable medical devices, with a strong focus on PGA-based sutures and other medical products. The company leverages China’s manufacturing capabilities to produce cost-competitive PGA medical devices that meet international quality standards while addressing the growing demand for biodegradable medical solutions.

Innovation Initiatives:

• Manufacturing of PGA sutures with consistent quality and performance

• Development of specialized PGA formulations for specific medical applications

• Expansion of international regulatory certifications for medical device exports

Get Full Report Here: Polyglycolic Acid Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Polyglycolic Acid Is Sustainable and High-Performance

The Polyglycolic Acid market is undergoing a revolutionary transformation. While traditional polymers still dominate many applications, the industry is investing significantly in biodegradable alternatives, advanced polymerization technologies, and application-specific PGA formulations.

📈 Key Trends Shaping the Market:

• Rapid capacity expansion in China with multiple large-scale PGA production facilities

• Regulatory push for biodegradable materials in packaging and single-use products

• Technological advancements in copolymerization for enhanced material properties

• Growing adoption in oil and gas sector for environmentally conscious well stimulation

Get Full Report Here: Polyglycolic Acid Market – View in Detailed Research Report

The companies listed above are not only producing innovative biodegradable materials—they’re spearheading the sustainable transformation of multiple industries from healthcare to energy.